Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The Vanderbilt University Medical Center (VUMC) is looking to transform electronic health records (EHRs) by leveraging voice and AI technology to allow EHRs to naturally interact with physicians to find relevant information and hopefully enhance patient care.
Researchers at Georgia Tech have developed a new AI-based app, MyPath, that adapts to each stage of a patient’s cancer journey with personalized resources and recommendations on everything from side effects to insurance and more.
Researchers from the Imperial College London and the University of Melbourne created a new AI algorithm that is four times more accurate in predicting survival rates among ovarian cancer patients. The tool was also able to determine the most effective treatment for patients who exhibit ovarian cancer. Research findings were published in Nature Communications.
Flagler Hospital, a 335-bed community hospital based in St. Augustine, Florida, is projected to save more than $20 million after AI technology helped it reduce costs, average length of stay and readmissions for pneumonia patients.
Medical device company Sight Diagnostics has raised $27.8 million in funding to expand its system that uses AI to analyze blood tests, according to a report by VentureBeat.
IBM Watson Health is partnering with the Broad Institute of MIT and Harvard to use AI and genomics to help clinicians better predict the onset of serious cardiovascular diseases, the company announced Feb. 13.
Researchers at West Virginia University (WVU) were awarded a $1 million grant from the National Institute of Justice to develop novel AI techniques to combat the opioid epidemic and opioid trafficking. The funding will be provided over a three-year period.
What to do with wearables and the deluge of data they offer is a big question in the minds of IT leaders and a topic addressed well at HIMSS19 by Karl Poterack, MD, the medical director, applied clinical informatics, Mayo Clinic.
The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns.
If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?